Literature DB >> 24292777

Surgical management of cervical spondylotic myelopathy - indications for anterior, posterior or combined procedures for decompression and stabilisation.

Stefan Alexander König1, Uwe Spetzger.   

Abstract

BACKGROUND: The authors describe their experience with the choice of anterior, posterior and combined approaches for the surgical treatment of spondylotic myelopathy.
METHODS: Description of surgical anatomy, surgical technique, indications, limitations, complications, specific perioperative considerations and specific information to give to the patient about surgery and potential risks and a summary of 10 key points is given.
CONCLUSIONS: If the disease extends behind the posterior vertebral body and if reestablishing spinal sagittal and coronal balance is an aim, then the anterior approach is the best choice. In cases of predominant posterior spinal cord compression and lordotic configuration the posterior approach should be preferred. Decompression of three or more levels, especially in combination with poor bone quality, requires a combined approach.

Entities:  

Mesh:

Year:  2013        PMID: 24292777     DOI: 10.1007/s00701-013-1955-y

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  3 in total

1.  Perioperative Risks Associated with Cervical Spondylotic Myelopathy Based on Surgical Treatment Strategies.

Authors:  Angel Macagno; Shian Liu; Bryan J Marascalchi; Sun Yang; Anthony J Boniello; John A Bendo; Virginie C Lafage; Peter G Passias
Journal:  Int J Spine Surg       Date:  2015-06-19

2.  Clinical outcome of anterior vs posterior approach for cervical spondylotic myelopathy.

Authors:  Mario Alberto Cahueque Lemus; Andres Enrique Cobar Bustamante; Alfredo Ortiz Muciño; Gustavo Caldera Hernandez
Journal:  J Orthop       Date:  2016-03-26

3.  Different Approaches for Treating Multilevel Cervical Spondylotic Myelopathy: A Retrospective Study of 153 Cases from a Single Spinal Center.

Authors:  Xiumao Li; Liang Jiang; Zhongjun Liu; Xiaoguang Liu; Hua Zhang; Hua Zhou; Feng Wei; Miao Yu; Fengliang Wu
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.